Slide Slide

Welcome to

Oniosome Healthcare Private Limited.

Oniosome healthcare is a contract research organization (CRO)and innovation service provider, involved in the development and commercialization of scientifically proven innovative healthcare products based on the principle of Novel Drug Delivery Systems (NDDS) and exploration of new formulation strategies.
In addition to product research and development, Oniosome helps test drugs for safety, efficacy (in vitro and in vivo), pre-clinical animal studies in a GLP facility, and R&D of highly potent compounds.

OUR PROMISE

Growth with Caring & Sharing   

We will, with utmost care for the environment and society, continue to enhance value for our customers by providing innovative products and economically efficient solutions; and for our stakeholders through growth, cost effectiveness and wise investment of resources.  

SERVICES

There are changes, challenges and opportunities, In order to seize these opportunities; we are putting forth a systematic effort powered by expert and professional planning and implementation.

Pharma Process development and scale up

Biotech process development and scaleup

Analytical Development & Bioassays

Learning

CONTRACT RESEARCH/MANUFACTURING & MARKETING 

We have completely integrated R&D, technology and engineering capabilities that enable us to be cost effective partners on a sustainable basis. We have built strong alliances and continuing relationships with top global generic companies to offer R&D and formulation development services.

The Contract Manufacturing Division is being set up to address the challenges and opportunities created due to increasing R&D costs, low R&D productivity, impending patent expirations and at the same time, pressure to reduce healthcare costs. This in turn has propelled global pharma majors to cut costs and improve overall profitability

CONTRACT RESEARCH/MANUFACTURING & MARKETING 

We have completely integrated R&D, technology and engineering capabilities that enable us to be cost effective partners on a sustainable basis. We have built strong alliances and continuing relationships with top global generic companies to offer R&D and formulation development services. The Contract Manufacturing Division is being set up to address the challenges and opportunities created due to increasing R&D costs, low R&D productivity, impending patent expirations and at the same time, pressure to reduce healthcare costs. This in turn has propelled global pharma majors to cut costs and improve overall profitability.

TEAM

Capable team of experienced Scientist in the domain of Pharma& Biotech .

BUSINESS MODEL

Integrated business model creating a 'one stop' shop

R & D

Strong Research and development capabilities with Low cost manufacturing base

SKILLS

regulatory skills for compliance and adherence

COLLABORATION & OUT LICENSING OPPORTUNITIES

Oniosome is committed to developing new formulations and has embarked on forging out-licensing agreements and we seek out-licensing strategic partnerships with Pharma and Biotech companies.

Oniosome has state-of-the-art research facilities led by team of highly qualified scientists. This enables us to develop new generation drugs, formulations and novel drug delivery vehicles.

Oniosome has collaboration with academia, hospitals and other research-based organizations, this gives us access to valuable assets like expert scientists & sophisticated infrastructure.

Have you any question or query ?

Why ONIOSOME as a Partner of Choice

Oniosome is dedicated to serving the pharmaceutical & Biotech and related industries to support discovery and development of pharmaceutical & Biotech products

Understanding the importance of quality and reliability and dynamics of being a service provider

Access to a well-equipped development facility for customized products.

Ability to manage integrate operations to maximise cost efficiency

Quick and seamless support for assistance at all stage of product development, scale-up, manufacturing, and scientific support for marketing